Insights on Global Normal Balloon Catheter Market Offering Trends, Share, Size, Growth Until the End of 2022

As per the current market trends and the promising nature of the normal balloon catheter market, it can be estimated that the future holds positive outcomes. In order to provide a deep insight about the concerned market, Fact.MR would be publishing a resourceful analysis that will enclose knowledge about the regional market size, revenue and opportunity status. Readers will be offered the privilege to decode various facets of the market during the period “2017 to 2022”, together with the active access to secondary and primary research methodology. Furthermore, various segments of the market associated to product, application, end-user etc., would also be present in this intelligent research report.

Request for Free Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=147

Normal balloon catheter, an innovative medical device, comprises a catheter and a guidewire that is inserted into femoral artery in the legs, or, sometimes into radial artery in arms for treating constricted blood vessels. Generally normal balloon catheter is utilized for preventing blood vessel constriction, which is caused by atherosclerosis, i.e. deposition of the lipid substances in blood vessels.

The surge in interventional cardiology has been facilitating the utilization of normal balloon catheters. Moreover, there is a rise in prevalence of patients affected with the end stage renal disease. The number of patients seeking for renal replacement therapy has also increased. Leading manufacturers of normal balloon catheters are developing efficient and cost-effective solutions. These incidences might influence growth of the global normal balloon catheter market in the upcoming years. In contrast, costs of angioplasty procedures are very high, coupled with the risks such as artery collapse and infection related to balloon catheterization, which in turn will impede growth of the market.

The number of cardiovascular diseases has been witnessing a rise, along with growing cases of cardiology intervention procedures worldwide. Several governments are providing reimbursement support for people suffering from vascular diseases. There has also been a hike in healthcare expenditure. These factors might favor demand for normal balloon catheters. In addition, various other factors such as growing geriatric population, rising investments in research & development activities concerning normal balloon catheters are expected to pave potential growth opportunities for manufacturers of normal balloon catheters. The global market for balloon catheter is likely to exhibit a moderate growth during 2017 to 2022. Revenues from the global market for normal balloon catheter will reach nearly US$ 2,000 Mn by 2022-end.

Europe to Account for the Largest Revenue Share of the Market during 2017 to 2022

In terms of revenues, Europe will account for the largest share of the market during the forecast period. Europe will continue to be the most lucrative market for normal balloon catheter. Sales of normal balloon catheter in Asia-Pacific excluding Japan (APEJ) will register the highest CAGR through 2022. In contrast, sales of normal balloon catheter in North America will exhibit the lowest CAGR in the market through 2022.

By indication, coronary artery disease will remain dominant in the global market, with sales poised to surpass US$ 1,000 Mn in revenues by 2022-end. Approximately three-fourth revenue share of the market will be accounted by sales of normal balloon catheter for coronary artery disease during 2017 to 2022.

Browse Full Report with TOC- https://www.factmr.com/report/147/normal-balloon-catheter-market

Hospitals to Remain the Largest End-Users of Normal Balloon Catheter

Sales of normal balloon catheter in cardiac catheterization laboratories are expected to exhibit the fastest expansion through 2022, based on end-users. Hospitals will remain the largest end-users of normal balloon catheter throughout the forecast period.

Nylon will continue to be the preferred raw material for manufacturing normal balloon catheter. Nearly half revenue share of the market will be accounted by nylon, based on raw material. However, sales of polyurethane for production of normal balloon catheter will register a comparatively higher CAGR than sales of nylon through 2022.

Competition Tracking

Key players profiled in Fact.MR’s report include Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, Terumo Corporation, MicroPort Scientific Corporation, B. Braun Melsungen AG, Meril Life Sciences Pvt. Ltd., Hexacath, Tokai Medical Products Inc., Cook Medical INC, Cordis Corporation, and BIOTRONIK SE & Co. KG.

Table of Content

Global Normal Balloon Catheter Market - Executive Summary
Global Normal Balloon Catheter Market Overview
2.1. Introduction
       2.1.1. Global Normal Balloon Catheter Market Taxonomy
       2.1.2. Global Normal Balloon Catheter Market Definition
2.2. Global Normal Balloon Catheter Market Size (US$ Mn) and Forecast, 2012-2022
       2.2.1. Global Normal Balloon Catheter Market Y-o-Y Growth
2.3. Global Normal Balloon Catheter Market Dynamics
       2.3.1. Drivers
       2.3.2. Restraints
       2.3.3. Trends
2.4. Supply Chain
2.5. Epidemiology
2.6. Product Mapping Behavior By Region
2.7. Average Pricing Analysis 
2.8. Regulations
2.9. Key Participants Market Presence (Intensity Map) By Region

Read More>>>

Request Discount of this Report- https://www.factmr.com/connectus/sample?flag=D&rep_id=147

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Fact.MR
Suite 9884
27 Upper Pembroke Street,
Dublin 2, Ireland
Telephone: +353-1-6111-593
Email: sales@factmr.com/ 
Web: https://www.factmr.com/

This release was published on openPR.